TY - JOUR
T1 - 6,6′-dihydroxythiobinupharidine (Dtbn) purified from nuphar lutea leaves is an inhibitor of protein kinase c catalytic activity
AU - Waidha, Kamran
AU - Anto, Nikhil Ponnoor
AU - Jayaram, Divya Ram
AU - Golan-Goldhirsh, Avi
AU - Rajendran, Saravanakumar
AU - Livneh, Etta
AU - Gopas, Jacob
N1 - Funding Information:
Funding: This research was supported by The Israel Science Foundation (grant No. 1864/16 [E.L., D.R.J. and N.P.A.]. Grant (No. 3-0-7374) from the Israel Ministry of Health [A.G.G. and J.G.].
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/1/1
Y1 - 2021/1/1
N2 - Water lily (Nuphar) bioactive extracts have been widely used in traditional medicine owing to their multiple applications against human ailments. Phyto-active Nuphar extracts and their purified and synthetic derivatives have attracted the attention of ethnobotanists and biochemists. Here, we report that 6,6′-dihydroxythiobinupharidine (DTBN), purified from extracts of Nuphar lutea (L.) Sm. leaves, is an effective inhibitor of the kinase activity of members of the protein kinase C (PKC) family using in vitro and in silico approaches. We demonstrate that members of the conventional subfamily of PKCs, PKCα and PKCγ, were more sensitive to DTBN inhibition as compared to novel or atypical PKCs. Molecular docking analysis demonstrated the interaction of DTBN, with the kinase domain of PKCs depicting the best affinity towards conventional PKCs, in accordance with our in vitro kinase activity data. The current study reveals novel targets for DTBN activity, functioning as an inhibitor for PKCs kinase activity. Thus, this and other data indicate that DTBN modulates key cellular signal transduction pathways relevant to disease biology, including cancer.
AB - Water lily (Nuphar) bioactive extracts have been widely used in traditional medicine owing to their multiple applications against human ailments. Phyto-active Nuphar extracts and their purified and synthetic derivatives have attracted the attention of ethnobotanists and biochemists. Here, we report that 6,6′-dihydroxythiobinupharidine (DTBN), purified from extracts of Nuphar lutea (L.) Sm. leaves, is an effective inhibitor of the kinase activity of members of the protein kinase C (PKC) family using in vitro and in silico approaches. We demonstrate that members of the conventional subfamily of PKCs, PKCα and PKCγ, were more sensitive to DTBN inhibition as compared to novel or atypical PKCs. Molecular docking analysis demonstrated the interaction of DTBN, with the kinase domain of PKCs depicting the best affinity towards conventional PKCs, in accordance with our in vitro kinase activity data. The current study reveals novel targets for DTBN activity, functioning as an inhibitor for PKCs kinase activity. Thus, this and other data indicate that DTBN modulates key cellular signal transduction pathways relevant to disease biology, including cancer.
KW - 6,6-dihydroxythiobinupharidine (DTBN)
KW - Homology docking modeling
KW - Kinase inhibitor
KW - Nuphar lutea
KW - Protein kinase C (PKC)
KW - Ramachandran plot
UR - http://www.scopus.com/inward/record.url?scp=85106334253&partnerID=8YFLogxK
U2 - 10.3390/molecules26092785
DO - 10.3390/molecules26092785
M3 - Article
C2 - 34066895
AN - SCOPUS:85106334253
SN - 1420-3049
VL - 26
JO - Molecules
JF - Molecules
IS - 9
M1 - 2785
ER -